Used as an intermediate in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Its structure supports the design of compounds with enhanced blood-brain barrier permeability. Commonly employed in the preparation of psychotropic agents and cognitive enhancers due to the piperazine core’s affinity for neurotransmitter receptors. Also utilized in research settings for structure-activity relationship (SAR) studies to optimize drug efficacy and selectivity.